Nanobiotix Issues Statement Regarding Recent Media Speculation Concerning Intentions For A Potential Public Takeover; Says There Is No Such Intention To Acquire Control Of The Company, And No Process Or Assessment Is Being Conducted Toward That End

Nanobiotix (NASDAQ: NBTX), a biotechnology company focused on cancer treatment, has issued a statement denying recent media speculation about a potential public takeover. The company clarified that there is no intention to acquire control of Nanobiotix and that no processes or assessments related to a takeover are currently underway. Furthermore, they noted factual inaccuracies in the media reports that contradict their latest public disclosures.